Glucocorticoids cause a 10-fold increase in hepatic phosphoenolpyruvate carboxykinase (PEPCK) gene transcription through two low affinity glucocorticoid receptor (GR) binding sites and a complex array of accessory factor DNA elements and associated proteins. To analyze how co-activators interact with the GR in this context, we took advantage of the C656G GR mutant that binds ligand with very high affinity. This GR activates PEPCK gene transcription at a 500-fold lower dexamethasone concentration than does wild type GR. Transfected C656G GR containing additional mutations or deletions was tested on PEPCK gene expression in H4IIE hepatoma cells. We found that the AF2 domain is the only one of the three defined transactivation domains in GR that is required for PEPCK gene expression and that mutation of this domain disrupts the direct interaction of GR with steroid receptor coactivator 1 (SRC-1). These data help define the functional interaction between GR and SRC-1 and further define the role of the GR in glucocorticoid-mediated expression of the PEPCK gene.
Glucocorticoids cause a 10-fold increase in hepatic phosphoenolpyruvate carboxykinase (PEPCK) gene transcription through two low affinity glucocorticoid receptor (GR) binding sites and a complex array of accessory factor DNA elements and associated proteins. To analyze how co-activators interact with the GR in this context, we took advantage of the C656G GR mutant that binds ligand with very high affinity. This GR activates PEPCK gene transcription at a 500-fold lower dexamethasone concentration than does wild type GR. Transfected C656G GR containing additional mutations or deletions was tested on PEPCK gene expression in H4IIE hepatoma cells. We found that the AF2 domain is the only one of the three defined transactivation domains in GR that is required for PEPCK gene expression and that mutation of this domain disrupts the direct interaction of GR with steroid receptor coactivator 1 (SRC-1). These data help define the functional interaction between GR and SRC-1 and further define the role of the GR in glucocorticoid-mediated expression of the PEPCK gene.
Glucocorticoids (GCs)
1 play a central role in carbohydrate metabolism by increasing glucose production, decreasing glucose tolerance, and causing insulin resistance (1) . GCs increase glucose production primarily by inducing the transcription of genes that encode gluconeogenic enzymes, including PEPCK, a rate-determining enzyme of gluconeogenesis. GCs increase the rate of transcription of the PEPCK gene by ϳ10-fold (2) through a multicomponent glucocorticoid response unit. The glucocorticoid response unit consists of a tandem array of four accessory factor elements (gAF1-4) 2 that bind HNF4/COUP-TF, HNF3, COUP-TF, and C/EBP␤, respectively, and two nonconsensus glucocorticoid response elements (GR1, GR2) (see Fig. 6 , inset) (3, 4) . The GR binds to the GR1 and GR2 elements 10 -20 times less avidly than to a consensus GRE (5) , and GR1 and GR2 are unable to confer glucocorticoid responsiveness by themselves (6) . Mutations that disrupt the binding of GR to GR1 result in a more severe reduction of the GC response than does disruption of binding to GR2 (5) .
GR belongs to the superfamily of steroid/thyroid/retinoic acid receptor proteins that function as ligand-dependent transcription factors (7) . Two transactivation domains (referred to as 1 and 2) were originally identified in the human GR (hGR) (8 -12 ). An additional region involved in transactivation, AF2, has been mapped (see Fig. 2A , inset) (13) (14) (15) . The 2 and AF2 domains are both located in the ligand-binding domain (LBD) in the C-terminal regions of GR. The 1 domain (also referred to as enh2 or AF-1; residues 77-262 in hGR or 106 -318 in rat GR (rGR)) is located in the N-terminal region of the GR molecule and is generally considered a major region responsible for transactivation. 1 makes contact with proteins in the basal transcriptional apparatus, including the TATA box-binding protein (TBP), possibly through an intermediary adapter protein(s) (16 -18) . The 1 domain is highly acidic and phosphorylated (19, 20) and it may undergo interdomain interactions consequent to DNA binding (21) . The 2 domain (residues 526 -556 in hGR or 544 -573 in rGR) possesses transactivation potential in the context of full-length GR (22) , nuclear matrix targeting activity (23) , and a binding domain for hsp90 (24) . The C-terminal AF2 domain (sometimes called c; residues 727-763 in hGR (25) or 745-781 in rGR, determined also as 752-758 in hGR (26)) forms part of the amphipathic ␣-helix 12 of the ligand binding domain and is responsible for the hormonedependent interaction with coactivators of the p160 family, e.g. SRC-1 (27, 28) . This interaction with coactivators may occur because of the conformational change AF2 undergoes upon ligand binding (29, 30) , but the exact residues have not been defined.
Two conditions had to be met in order to study the exact contribution of the three transactivation domains of GR to PEPCK gene transcription: 1) the contribution of the endogenous GR in H4IIE hepatoma cells used for analyzing GCstimulated PEPCK gene transcription had to be eliminated; and 2) GR mutations that disrupt the transactivation potential of each TAD, while maintaining the ligand and DNA binding properties of GR, had to be constructed. In this study we employed a system that eliminates the influence of the endogenous GR by using GR C656G (31) . This mutant receptor is maximally activated by glucocorticoids at 500 times less ligand than is required for activation of the endogenous, wild type GR, thereby eliminating the influence of the latter. We used this system and a series of mutations of C656G GR to demonstrate the unique importance of the AF2 domain for induction of the PEPCK gene by glucocorticoids.
EXPERIMENTAL PROCEDURES
Plasmids-The construction of the reporter plasmids pPL32 (PEPCK-CAT) and PEPCK-LUC has been described previously (32, 33) . The plasmids p6R-GR, p6R-GR C656G were obtained from Dr. Keith Yamamoto (University of California, San Francisco). The TAD GR mutants menh2, mtau2, and mAF2 were constructed using the Quickchange site-directed mutagenesis kit (Stratagene). The GAL4 plasmids used were constructed as described previously (34, 35) . Yeast plasmids pGBT9-GR (36), pGAD424-SRC1, and pGAD424 (37) were obtained from Dr. Michael Stallcup (University of Southern California, Los Angeles). The mutations mAF2 and mAF2/Y7532 of pGBT9-GR were constructed using the Quick-change site-directed mutagenesis kit (Stratagene).
Transient Transfection-H4IIE and COS cells were maintained and transfected by calcium phosphate precipitation as described previously (3, 32, 35, 38) . H4IIE cells were incubated in ␣-modified Eagle's medium containing 10% fetal bovine serum and COS cells in DMEM containing 10% fetal bovine serum. After transfection and following 20% Me 2 SO treatment for 3 min, H4IIE cells were treated with 1 nM Dex (as established in this study, see Fig. 1 ). Cells were harvested after an 18-h incubation and lysed with reporter lysis buffer (Promega). Chloramphenicol acetyltransferase (CAT) or luciferase activities were measured and normalized for the protein concentration, which was quantitated using the Bio-Rad reagent.
Western Blot Analysis-GR expression vectors (40 g) were transfected into COS cells. Whole cell extracts were prepared after an 18 h incubation using lysis buffer (0.2% Triton X-100, 5% glycerol, 20 mM tetrasodium diphosphate, 20 mM Tris, 1 mM EDTA, 1 mM EGTA, 1 mM trisodium vanadate, 1 M dithiothreitol, 0.125 M okadaic acid) containing a protease inhibitor mixture of 0.5 M phenylmethylsulfonyl fluoride, 1 g/ml pepstatin and leupeptin, and 0.5 g/ml aprotinin. Cell lysates were incubated with antibodies directed against GR (Santa Cruz Biotechnology) for 1.5 h followed by the addition of protein ASepharose. Protein A-Sepharose-antibody complexes were isolated by centrifugation, washed, and dissolved in 2ϫ SDS loading buffer and boiled for 5 min. Proteins were separated on 4 -12% gradient bis-Tris gels (Invitrogen) and transferred to a nitrocellulose membrane for immunoblot analysis with the Western Breeze kit (Invitrogen).
Ligand Binding Studies-GR expression vectors (20 g) were transfected into COS cells. The cells were serum-starved for 16 h after a 24-h incubation in DMEM containing 10% fetal bovine serum. Cells were treated with 0.1, 1, 5, 10 and 20 nM [1,2,4-3 H] dexamethasone (Amersham Biosciences) for 1 h at 37°C. A parallel sample incubated with a 200-fold molar excess of unlabeled Dex was used to estimate nonspecific binding. Cells were washed twice in serum-free medium, harvested, centrifuged, and lysed for 5 min in lysis buffer (25 mM Tris, 150 mM sodium chloride, 1% Triton X-100). Cell lysates were mixed 1:2 with the scintillation liquid Microscint 40 (Packard), and radioactivity was measured in a scintillation counter. The software GraphPad Prism 3 was used for the analysis of binding.
Yeast Two-hybrid System-The yeast strain HF7c, which stably expresses the ␤-galactosidase reporter (lacZ), was transformed by the lithium acetate method using the YEASTMAKER transformation kit (CLONTECH). Transformed colonies were incubated for 36 h in synthetic drop-out medium lacking leucine, tryptophan, and histidine followed by incubation for 18 h in YPD (yeast extract, peptone, dextrose) medium (CLONTECH) with or without 10 M deoxycorticosterone. Deoxycorticosterone was used instead of dexamethasone, because dexamethasone is inactive in yeast cells. Cells were lysed by three freezethaw cycles in liquid nitrogen. ␤-Galactosidase activity was measured using o-nitrophenyl-␤-D-galactopyranoside substrate (ONPG, Calbiochem) according to the CLONTECH manual and calculated in specific units/cell: (A/A 600 ) ϫ (1000/t ϫ v ϫ F), where A 420 is the absorbance at 420 nm from the galactosidase assay, A 600 is the absorbance at 600 nm of 1 ml of the yeast culture, t is the time of incubation, v is the volume of the yeast culture used for the galactosidase assay, and F is the dilution factor (36) .
RESULTS

Endogenous GR in H4IIE Hepatoma Cells Can Be Circumvented, Thus Allowing a Study of the Involvement of Each TAD
of the Receptor-Glucocorticoid (GC)-regulated gene expression usually requires the binding of the glucocorticoid receptor (GR) to DNA. The C656G mutation of rGR increases the affinity of ligand binding to this receptor, which then is capable of activating transcription at a lower ligand concentration (31) . Reasoning that this sensitive GR could be used to bypass the influence of the endogenous GR in H4IIE cells, we first measured the response of the PEPCK gene to Dex in the presence of C656G GR or in its absence (endogenous wild type GR). As demonstrated in Fig. 1 , half-maximal activation of C656G GR occurs at a 500-fold lower concentration of Dex than is required for activation of transcription by the endogenous receptor. Significant induction (ϳ8-fold) occurs at a 1 nM concentration, which is ineffective in cells that contain just the wild type receptor. Thus, mutations of the various transactivation domains (TAD) in C656G GR can be tested in the presence of 1 nM Dex without the influence of endogenous GR.
The AF2 Transactivation Domain Is Required for Induction of the PEPCK Gene by Glucocorticoids-The first TAD tested was enh2/1/AF1. Three amino acid substitutions (E219K, F220L, and W234R) disrupt the transcriptional activation function of enh2 (39) . This triple mutation, referred to as menh2, does not decrease the Dex-induced expression from the PEPCK gene promoter-driven reporter construct ( Fig. 2A) . Also, the entire enh2/1/AF1 domain encompassing about 180 amino acids in the C terminus of C656G GR was deleted (referred to as denh2 in Fig. 2A) , and no decrease in the Dex induction of the PEPCK gene was observed ( Fig. 2A) . It thus appears that the enh2/1/AF1 domain of GR is not involved in PEPCK gene expression.
The 2 domain, which contributes to the overall transactivation function of the full-length GR (22) , was studied next. Mutation S561A in the 2 domain of mouse GR causes a loss of FIG. 1. C656G GR is more sensitive to Dex than the endogenous GR. H4IIE cells were transiently transfected with 10 g of the pPL32 promoter construct (the PEPCK gene promoter encompassing nucleotides Ϫ467 to ϩ65 relative to the transcription start site, ligated to the CAT reporter gene) and 5 g of the expression plasmid C656G GR or an equivalent amount of the empty pSV-neo vector as described previously (32, 38) . Cells were treated with increasing concentrations of Dex (from 1 pM to 1 M) for 18 h in serum-free DMEM. Cells were harvested, and CAT assays were performed. Results represent the mean Ϯ S.E. of at least five separate experiments.
transactivation function in both the minimal 2 fragment and the full-length GR (22) . Mutation S573A in the rat GR (a homologue of the S561A mutation in mouse GR (mGR), and referred to as mtau2 in Fig. 2A) , however, did not affect the activation of transcription of the PEPCK reporter gene as compared with the control (Fig. 2A) .
The C-terminal AF2 domain is the third TAD of GR. Mutation of residue Glu 911 in the human progesterone receptor alters the transactivation potential of this receptor without altering ligand binding affinity (40) . Residue Glu 773 in the rGR is homologous to this residue, and therefore the E773A point mutant was constructed in C656G GR. E773A (referred to as mAF2 in Fig. 2A ) decreases the response of the PEPCK reporter gene by Dex by 70%. C656G GR and mAF2 are both expressed equally in COS cells, and their expression does not depend on Dex treatment (Fig. 2B) . COS cells were used to test for GR expression levels because the low transfection efficiency of H4IIE cells precludes such an analysis. None of the mutant GRs tested in Fig. 2A affect basal PEPCK promoter activity.
The data presented above show that the AF2 domain of GR, which is important for coactivator interaction, is necessary for glucocorticoid-mediated induction of the PEPCK gene. It is possible that this AF2 mutant receptor has lost the ability to bind ligand and is unable to transactivate the wild type PEPCK promoter construct. Therefore, binding studies with 3 H-labeled Dex were performed. Only a small change in the binding affinity of mAF2 (from 1.5 nM Ϯ 1.2 for C656G GR to 5.4 Ϯ 2.0 nM for mAF2) was measured. We also tested the effect of mAF2 on PEPCK gene expression at higher ligand concentrations (10 and 100 nM dexamethasone) to confirm that ligand affinity was not responsible for the lack of PEPCK gene expression. mAF-2 was unable to activate PEPCK gene expression even at 100 nM dexamethasone (Fig. 3) . The effect seen was from endogenous GR.
The AF2 Mutant Is Active in the Context of a Palindromic GRE-We next tested whether the mAF2 GR could activate transcription from a PEPCK promoter-driven reporter gene construct in which the GR1 binding site has been changed to a high affinity, palindromic GRE. This construct no longer requires the function of the PEPCK gAF1 and gAF3 elements, which bind to HNF4 and COUP-TF, factors that help recruit the coactivator SRC-1 to the PEPCK promoter for glucocorticoid-mediated activation (5, 35, 41) . In contrast to the results observed for the wild type PEPCK gene promoter illustrated in Fig. 2A , the mAF2 GR displayed complete transactivation function at the PEPCK promoter in the presence of the high affinity GRE (Fig. 4) . These data suggest that this mutant receptor may have lost the ability to recruit certain coactivators, such as SRC-1, to the wild-type PEPCK gene promoter. (28) report that SRC-1 binds to a variety of nuclear receptors including GR. Furthermore, SRC-1 is an important coactivator for PEPCK gene transcription, which FIG. 3 . Effect of higher dexamethasone concentrations on PEPCK gene expression in the presence of mAF2. Experiments were performed as described in Fig. 2 except that the activation of both C656G and mAF2 were compared with endogenous GR in transient transfection experiments. Cells were treated with increasing concentrations of Dex (from 1 nM to 100 nM) for 18 h in serum-free DMEM. Results represent the mean Ϯ S.E. of at least five separate experiments.
E773A in the AF2 Domain Influences in Vivo Binding of GR to SRC-1-Ding et al.
FIG. 2. Involvement of the TADs of GR in Dex-induced PEPCK gene transcription.
A, H4IIE cells were transiently transfected with 5 g of the PEPCK-LUC reporter construct (the PEPCK gene promoter encompassing nucleotides Ϫ467 to ϩ65 relative to the transcription start site, ligated to the luciferase reporter gene) and 2.5 g of either a GR expression plasmid or an empty RSV-neo vector. Cells were treated with 1 nM Dex for 18 h in serum-free DMEM and harvested for the assay of luciferase activity. The GR expression vectors used are as follows: coGR, the C656G GR mutant; menh2, the triple mutation E219K,F220L,W234R; denh2, the deletion 106 -318 of the enh2/1/AF1 domain; mtau2, the S573A mutation; mAF2, the E773A mutation. The results represent the mean Ϯ S.E. of at least five experiments. The asterisks indicate a statistically significant difference (p Ͻ 0.05) from coGR. Panel B shows that the C656G GR AF2 mutants are expressed equally. The C656G GR and the corresponding AF2 GR mutants (40 g) were transfected into COS cells. Whole cell extracts were prepared and immunoprecipitated with GR antibodies for GR immunoblot analysis.
may be due to the direct binding of SRC-1 to GR (33) . It is possible, therefore, that mAF2 does not interact with SRC-1, which would explain its inability to transactivate the wt PEPCK gene promoter. The interaction of GR and SRC-1 was tested in a yeast two-hybrid system, and it was observed that, indeed, the binding of SRC-1 to GR is significantly decreased when the E773A (mAF2) mutation is introduced in the AF2 domain of the C656G GR (Fig. 5) . However, another AF2 mutation Y753F (mAF2/Y753F), which causes a 30% reduction in maximal activation of the rGR at the MMTV promoter (42), had no impact on the interaction of GR with SRC-1 (Fig. 5) . These data strongly suggest that the recruitment of SRC-1 to the AF2 domain of GR is necessary for glucocorticoid-mediated induction of the PEPCK gene.
The AF2 Domain of GR Is Involved in the Functional Interaction of SRC-1 and the GR-The effect of mAF2 on PEPCK gene promoter function was further examined to test the idea that SRC-1 recruitment to the GR on the PEPCK gene promoter may be disrupted by the AF2 mutation. Dex-induced expression is markedly decreased when the gAF2 element is converted to a binding site for the GAL4⅐DBD (gAF2 3 GAL4 PEPCK, see inset in Fig. 6 ). This is to be expected, because any mutation of this element that disrupts the binding of HNF3, the associated accessory factor, results in a 50 -70% reduction of the Dex response (34) . GAL4⅐SRC1 mediates accessory factor activity through the gAF2 element of the PEPCK glucocorticoid response unit when this element is changed to a GAL4 binding site (33) . As shown in Fig. 6 , the binding of a GAL4⅐SRC-1 chimeric protein to this site restores the response to 1 nM Dex through a gAF2 3 GAL4 PEPCK luciferase construct in the presence of C656G GR. However, GAL4⅐SRC1 is not able to restore Dex-induced PEPCK reporter gene expression when mAF2 is employed (Fig. 6) , suggesting a loss of functional interaction between GR and SRC-1.
DISCUSSION
Three cysteine residues (Cys 640 , Cys 656 , and Cys 661 ) are involved in the GR-ligand interaction. The point mutations C640S and C661S each reduces the affinity of glucocorticoid binding to GR. Surprisingly, mutation C656G increases the affinity of the GR for its ligand and also activates transcription at a lower ligand concentration (31) . As we show in this study, half-maximal activation of expression from a PEPCK gene promoter-driven reporter construct in H4IIE cells is achieved at a 500-fold lower ligand concentration when C656G GR is used. Because significant activation occurs at 1 nM Dex, a concentration at which wild type GR is inactive vis-´a-vis the PEPCK gene, one can bypass the endogenous, wild type GR and thereby analyze the function of different regions of a transfected GR (Fig. 1) .
Two hGR domains, referred to as 1 and 2, are necessary for activation of transcription but are not specifically involved in either steroid or DNA binding (9) . These hGR transactivation domains were defined according to two criteria: 1) deletion of the domain decreases activity and 2) duplication of the domain increases activity (12) . We show that deletion of the enh2/1/ AF1 domain in rGR (Fig. 2) does not decrease the activation of PEPCK gene transcription promoted by glucocorticoids. This observation does not speak against the transactivation function of this domain but rather speaks for the fact that different activation surfaces of GR are employed in different GRE and promoter contexts. For example, deletion of the enh2/1/AF1 domain in the rGR does not affect the activation of the tyrosine aminotransferase promoter, but this mutation completely abrogates the activation of the MMTV-LTR promoter by hormone Experiments were performed as described in the legend to Fig. 2 except that the gAF2 3 GAL4 PEPCK luciferase construct, in which the gAF2 element of the PEPCK gene promoter is replaced with a GAL4 binding site, was used. C656G GR and mAF2 (2.5 g) were cotransfected with 2 g of either a GAL4⅐SRC-1 or GAL4⅐DBD expression vector. Results represent the mean Ϯ S.E. of at least five experiments. (39) . Distinct GR surfaces also mediate the cytotoxic and cytostatic effects of glucocorticoids (43) .
Three amino acid substitutions in the enh2/1/AF1 domain (E219K, F220L, W234R) selectively disrupt the activation function of this N-terminal TAD in GR (39) . This triple mutation does not influence PEPCK gene transcription (Fig. 2) , and hence GC regulation of the PEPCK gene must be conferred by one or both of the C-terminal TADs. The hinge region of steroid receptors, which includes the 2 domain, interacts with the general transcription factor, TAFII30, in vitro (44) and a novel coactivator, L7/SPA, in vivo (45) , but no evidence exists for the interaction of the 2 domain with the p160 coactivator family (SRC-1, GRIP1/TIF2, and p/CIP) (22) . S573A in rGR is homologous to S561A in mGR that causes a loss of transactivation activity in the minimum 2 fragment and the full-length GR (22) . The disruption of the 2 transactivation domain by point mutation S573A also does not diminish the activation of PEPCK gene (Fig. 2) . By contrast, a point mutation, E773A (mAF2), in the AF2 transactivation domain, which is known to interact with coactivators, does decrease the response of the PEPCK reporter gene to Dex by 70%. However, the mAF2 GR does not affect activation of transcription through a PEPCK promoter construct that contains a palindromic GRE in the place of GR1. It is noteworthy that this replacement relieves the requirement for gAF1 and gAF3 (5) . These accessory factor elements bind HNF4/COUP-TF and COUP-TF, respectively, an interaction that affects the affinity and stability of GR binding to GR1, and thus perhaps influence the interaction of SRC-1 with GR (46) . The palindromic GRE may therefore present a surface of GR that is sufficient, in itself, to interact with SRC-1.
Although it is known that the AF2 domain of GR is involved in the interaction with SRC-1 in vivo (28) , the GR residue(s) necessary for this interaction are unknown. We show here that the GR⅐SRC-1 interaction is interrupted when the E773A mutation is introduced into the GR (Fig. 6 ). There is specificity to this reaction because another AF2 mutation, Y753F, which displays reduced activation of the MMTV promoter (42) , has no influence on the GR⅐SRC-1 interaction in the yeast two-hybrid system (Fig. 5) .
In this study we further demonstrate the utility of using C656G GR to eliminate the function of endogenous GR. This Dex-sensitive GR allowed us to identify the transactivation domains of GR necessary for transcription of the PEPCK gene, which was heretofore not possible. Instead of possessing high affinity GREs, the PEPCK gene promoter has two low affinity GR binding sites, GR1 and GR2, and thus requires accessory factor activity to stabilize GR binding and to recruit coactivators to the promoter. We have identified a residue, Glu 773 , that directs the interaction of GR with SRC-1 in the context of the PEPCK gene promoter. Mutation of this residue does not disrupt activation of the PEPCK gene if the low affinity GR1 site is changed to a high affinity, palindromic GRE. These data suggest that a context-dependent conformation of GR is essential for the recruitment of SRC-1 to the PEPCK gene promoter and efficient glucocorticoid-mediated induction of this gene.
